Neuro-Degenerative Disease Clinical Trials
2 recruiting trials for Neuro-Degenerative Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Neuro-Degenerative Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Duke University (1), Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Retinal and Choroidal Imaging (device, 1 trial), followed by collection of data.
Track Neuro-Degenerative Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Retinal Imaging in Neurodegenerative Disease
This study aims to develop and evaluate biomarkers using non-invasive optical coherence tomography (OCT) and OCT angiography (OCTA) as well as ultra-widefield (UWF) fundus...
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Neuro-Degenerative Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Neuro-Degenerative Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Neuro-Degenerative Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.